Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  didanosine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Phase I/II Study of CTX/VCR/DOX/VP-16 with ddI, G-CSF, and CNS Prophylaxis/Therapy in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 07/92)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0162, NCI-T92-0039N, T92-0039
Phase I/II Study of ABV (DOX/BLEO/VCR) and ddI or ddC in Patients with Advanced AIDS-Related Kaposi's Sarcoma (Summary Last Modified 09/93)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 12
Sponsor: NIAID
Protocol IDs: NIAID-ACTG-163
Phase II Pilot Study of CDE (CTX/DOX/VP-16) and G-CSF plus ddI for HIV-Related Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 11/94)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: AECM-9312379, NCI-V94-0439
Phase II Study of CDE (CTX/DOX/VP-16) plus ddI for HIV-Related Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 08/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1494, E1494
Phase II Pilot Study of TRA and Antiretroviral Therapy in HIV-Related Kaposi's Sarcoma (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18 to less than 70
Sponsor: NCI
Protocol IDs: LAC-USC-17K911, NCI-T91-0126D, T91-0126
Start Over